Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Automated eligibility screening and monitoring for genotype-driven precision oncology trials.

Authors:
Michael H Eubank David M Hyman Amritha D Kanakamedala Stuart M Gardos Jonathan M Wills Peter D Stetson

J Am Med Inform Assoc 2016 07 25;23(4):777-81. Epub 2016 Mar 25.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY Division of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY.

The Information Systems Department at Memorial Sloan Kettering Cancer Center developed the DARWIN Cohort Management System (DCMS). The DCMS identifies and tracks cohorts of patients based on genotypic and clinical data. It assists researchers and treating physicians in enrolling patients to genotype-matched IRB-approved clinical trials. The DCMS sends automated, actionable, and secure email notifications to users with information about eligible or enrolled patients before their upcoming appointments. The system also captures investigators input via annotations on patient eligibility and preferences on future status updates. As of August 2015, the DCMS is tracking 159,893 patients on both clinical operations and research cohorts. 134 research cohorts have been established and track 64,473 patients. 51,192 of these have had one or more genomic tests including MSK-IMPACT, comprising the pool eligible for genotype-matched studies. This paper describes the design and evolution of this Informatics solution.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jamia/ocw020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370254PMC
July 2016

Publication Analysis

Top Keywords

patients
5
system captures
4
captures investigators
4
appointments system
4
upcoming appointments
4
enrolled patients
4
patients upcoming
4
investigators input
4
input annotations
4
future status
4
status updates
4
preferences future
4
eligibility preferences
4
annotations patient
4
patient eligibility
4
eligible enrolled
4
updates august
4
clinical trials
4
trials dcms
4
irb-approved clinical
4

Altmetric Statistics


Show full details
4 Total Shares
4 Tweets
4 Citations

Similar Publications

Are women with small endometriomas who undergo intracytoplasmic sperm injection at an elevated risk for adverse pregnancy, obstetric, and neonatal outcomes?

Authors:
Fatma Ferda Verit Ayse Seyma Ozsuer Kucukakca

Clin Exp Reprod Med 2021 Mar 18;48(1):80-84. Epub 2021 Feb 18.

Department of Obstetrics and Gynecology, Bezmialem Foundation University, Istanbul, Turkey.

Objective: The aim of the study was to investigate pregnancy, obstetric, and neonatal outcomes in women with small (<4 cm) unilateral endometriomas.

Methods: This retrospective study included 177 patients: 91 patients with small endometriomas and 86 controls with unexplained or tubal factor infertility who were treated at the Süleymaniye Gynecology and Maternity Training and Research Hospital Infertility Unit between January 2010 and July 2015. The groups were matched with regards to demographic characteristics such as age, body mass index, and infertility duration. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

High mRNA expression of GABA receptors in human sperm with oligoasthenoteratozoospermia and teratozoospermia and its association with sperm parameters and intracytoplasmic sperm injection outcomes.

Authors:
Paweena Kaewman Sutisa Nudmamud-Thanoi Patcharada Amatyakul Samur Thanoi

Clin Exp Reprod Med 2021 Mar 22;48(1):50-60. Epub 2021 Feb 22.

Department of Anatomy, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.

Objective: This study investigated the mRNA expression of gamma-aminobutyric acid (GABA) receptors in the sperm of oligoasthenoteratozoospermic (OAT) and teratozoospermic (TER) men compared to normozoospermic (NOR) men, as well as the relationships between GABA receptor expression and sperm parameters, fertilization rate, and embryo quality.

Methods: The mRNA expression of GABA A-α1 and GABA B-R2 receptors in sperm was examined using reverse transcription-polymerase chain reaction in three groups of patients: NOR (n=32), OAT (n=22), and TER (n=45). The fertilization rate and embryo quality were assessed in 35 patients undergoing Intracytoplasmic sperm injection (ICSI; 10 NOR, 10 OAT, and 15 TER men). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

The role of gonadotropin-releasing hormone agonists in female fertility preservation.

Authors:
Jae Hoon Lee Young Sik Choi

Clin Exp Reprod Med 2021 Mar 18;48(1):11-26. Epub 2021 Feb 18.

Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Advances in anticancer treatments have resulted in increasing survival rates among cancer patients. Accordingly, the quality of life after treatment, particularly the preservation of fertility, has gradually emerged as an essential consideration. Cryopreservation of embryos or unfertilized oocytes has been considered as the standard method of fertility preservation among young women facing gonadotoxic chemotherapy. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Hyperbaric oxygen for intracranial abscess.

Authors:
Edward O Tomoye Richard E Moon

Undersea Hyperb Med 2021 First Quarter;48(1):97-102

Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S.

The term "intracranial abscess" (ICA) includes cerebral abscess, subdural empyema, and epidural empyema, which share many diagnostic and therapeutic similarities and, frequently, very similar etiologies. Infection may occur and spread from a contiguous infection such as sinusitis, otitis, mastoiditis, or dental infection; hematogenous seeding; or cranial trauma. In view of the high morbidity and mortality of ICA and the fact that hyperbaric oxygen therapy (HBO2) is relatively non-invasive and carries a low complication rate, the risk-benefit ratio favors adjunct use of HBO2 therapy in selected patients with intracranial abscess. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Seizure during hyperbaric oxygen therapy: experience at a single academic hospital in Korea.

Authors:
Chan Hee Lee Jin Guel Choi Je Seop Lee Yoonsuk Lee Hyun Kim Yoon-Seop Kim Yong Sung Cha

Undersea Hyperb Med 2021 First Quarter;48(1):43-51

Department of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Background: Hyperbaric oxygen (HBO2) therapy is a safe and well-tolerated treatment modality. Seizures, one of the most severe central nervous system side effects of HBO2 therapy, can occur. Episodes of seizures during HBO2 therapy have not yet been reported in countries such as Korea, where hyperbaric medicine is still in the developmental stage. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap